Ciliatech

Ciliatech

Developing a new class of supraciliary implant for treating glaucoma

Location
—
Roles tracked
0
In pipeline
0
Tracking since
—

At a glance

You're tracking 0 roles at Ciliatech. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Medical Equipment Manufacturing
Company size
23 people
Headquarters
Chavanod, Auvergne-Rhône-Alpes
Founded
2017
Type
Privately Held
Total funding
$3.8M

CILIATECH is a medtech company specialized in ophthalmology, developing a new class of implant to address the increasing need to treat glaucoma durably with a novel design. Founded in 2017 by ophthalmic surgeon and inventor Dr. Philippe Sourdille and Olivier Benoit, a veteran engineer and biotech entrepreneur, CILIATECH developed the CID (Cilio-scleral Inter-positioning Device) groundbreaking concept ‘CID’ is the first implant in the industry to reduce IntraOcular Pressure (IOP) without needing to access the anterior chamber or create a subconjunctival filtration bleb. The device is implanted as a standalone procedure and in the latest trial has demonstrated efficacy in IOP lowering in both open angle glaucoma (POAG) and in narrow angle glaucoma - the latter is a real industry first. Implantation can be combined with cataract removal too. The company is located near Annecy, France - a beautiful region in the Western Alps which has been described as ‘the Alpine Venice’ www.cilia.tech

Ophthalmology surgery glaucoma implant and Medical Device

Open roles at Ciliatech